Advanced RET-fusion Non Small Cell Lung Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB15822 | Pralsetinib | A RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. |
Drug | Drug Name | Phase | Status | Count |
---|
Drug | Drug Name | Drug Description |
---|---|---|
DB15822 | Pralsetinib | A RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. |
Drug | Drug Name | Phase | Status | Count |
---|